Results 31 to 40 of about 229,203 (309)

Clinical Features of Hepatic Cirrhosis in Hypopituitarism [PDF]

open access: yesZhongguo quanke yixue, 2023
Background Hepatic cirrhosis represents the final stage for a wide variety of chronic liver diseases, which may be induced by numerous causes, and is associated with high mortality when complications arise.
SHI Xuexiu, YUN Wenjing, WANG Haixu, ZHAO Yingying, YANG Yanan, SUN Tongwen
doaj   +1 more source

Hepatite vírica crónica: proposta de um protocolo para o tratamento/seguimento da cirrose.

open access: yesActa Médica Portuguesa, 2008
Cirrhosis is the terminal phase of hepatic fibrosis, that leads to impaired hepatic function and blood flow. Liver cirrhosis is the final stage of many hepatic diseases characterized by chronic cellular destruction.
Vicens Diaz-Brito   +2 more
doaj   +1 more source

HEPATIC CIRRHOSIS

open access: yesThe Professional Medical Journal, 2011
Objective: To see the association of platelet count, splenomegaly and development of oesophageal varices. Study Design: Observational study. Duration of study: One year from January 2010 to December 2010. Setting: Gastroenterology Department, Medical Unit III, Nishtar Hospital Multan. Methodology: One hundred ten cirrhotic patients were included.
SALMA TANWEER   +4 more
openaire   +2 more sources

Effectiveness of COVID-19 Vaccination with mRNA Vaccines for Patients with Cirrhosis in Hungary: Multicentre Matched Cohort Study

open access: yesVaccines, 2022
Patients with cirrhosis are vulnerable to hepatic decompensation events and death following COVID-19 infection. Therefore, primary vaccination with COVID-19 vaccines is fundamental to reducing the risk of COVID-19 related deaths in patients with ...
Bálint Drácz   +7 more
doaj   +1 more source

Clinicodiagnostic value of functional morphological changes of intestine in encephalopathy development in cirrhosis [PDF]

open access: yesСаратовский научно-медицинский журнал, 2010
The aim of the article is to study frequency and expressiveness of clinico-morphological and dysbiotic intestinal changes in cirrhosis and to estimate its interrelation with manifestations of hepatic encephalopathy. 146 patients with cirrhosis ages 20 to
V.V. Ovsyannikova, I.V. Kozlova
doaj  

Transport of apolipoproteins A-I and A-II by human thoracic duct lymph [PDF]

open access: yes, 1981
The daily transport of human plasma apolipoproteins A-I and A-II, triglyceride, and total cholesterol from the thoracic duct lymph into plasma was measured in 2 subjects before and 3 subjects after renal transplantation. Lymph triglyceride transport was ~
Anderson, DW   +8 more
core   +1 more source

Comparison of Inflammatory Cytokine Levels in Hepatic and Jugular Veins of Patients with Cirrhosis

open access: yesMediators of Inflammation, 2023
Background. Systemic inflammation with elevated inflammatory cytokines is a hallmark in patients with cirrhosis and the main driver of decompensation. There is insufficient data on whether inflammatory cytokine levels differ between hepatic and jugular ...
Leonard Kaps   +11 more
doaj   +1 more source

Liver Resection for Primary Hepatic Neoplasms. [PDF]

open access: yes, 1988
Subtotal hepatic resection was performed in 356 patients; 87 had primary hepatic malignancies, 108 had metastatic tumors, and 161 had benign lesions including 8 traumatic injuries. The global mortality was 4.2%.
C. Couinaud   +16 more
core   +1 more source

Interleukin-22 predicts severity and death in advanced liver cirrhosis: a prospective cohort study [PDF]

open access: yes, 2012
Background: Interleukin-22 (IL-22), recently identified as a crucial parameter of pathology in experimental liver damage, may determine survival in clinical end-stage liver disease.
Bachmann, Malte   +11 more
core   +1 more source

Home - About - Disclaimer - Privacy